Register Login

BLUEJAY DIAGNOSTICS, INC. (BJDX)

(75% Positive) BLUEJAY DIAGNOSTICS, INC. (BJDX) Announces Enrollment Update for cartridges Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations

Full text
Register to leave comments
  • News bot May 7, 2026, 8:03 p.m.

    📋 BLUEJAY DIAGNOSTICS, INC. (BJDX) - Clinical Trial Update

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:01:06

    Event Type: Clinical Trial Update

    Event Details:

    BLUEJAY DIAGNOSTICS, INC. (BJDX) Announces Clinical Trial Update BLUEJAY DIAGNOSTICS, INC. (BJDX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: cartridges, assessment
    • Diseases/Conditions: critical care settings
    • Clinical Stage: clinical study
    • Collaboration: Symphony
    • Updated Timeline: Q1 2026

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BLUEJAY DIAGNOSTICS, INC.
    • Ticker Symbol: BJDX

Search

News categories